Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001829126-25-007253
Filing Date
2025-09-09
Accepted
2025-09-09 16:26:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 16780
  Complete submission text file 0001829126-25-007253.txt   18782
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Subject) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91725 | Film No.: 251303572
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11 WEST 42ND STREET, 9TH FLOOR NEW YORK NY 10036
Business Address 11 WEST 42ND STREET, 9TH FLOOR NEW YORK NY 10036 212-878-3523
Avenue Venture Opportunities Fund II, L.P. (Filed by) CIK: 0001886343 (see all company filings)

EIN.: 872781311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A